When your insurer refuses cashless treatment

A cashless authorisation under a health-insurance policy is a contractual entitlement, not a discretionary favour. It is mediated by the IRDAI (Health Insurance) Regulations, 2016, the IRDAI (Protection of Policyholders' Interests) Regulations, 2017, the IRDAI Master Circular on Standardisation in Health Insurance Business dated 22 July 2020 and the IRDAI Health Insurance (Standardisation) Guidelines, 2022, supplemented by the IRDAI Circular on "Cashless Everywhere" dated 31 January 2024. The regulator has prescribed turn-around-times for pre-authorisation and for final discharge, identified the third-party administrator's contractual role, and laid down the empanelment architecture of network hospitals. A refusal that breaches these turn-around-times — or a denial founded on a clause the insurer has waived through prior conduct — is reviewable through the IRDAI grievance route, the Insurance Ombudsman under the Insurance Ombudsman Rules, 1998 as superseded by the IRDAI Integrated Insurance Ombudsman Scheme, 2017 (amended 2021), the District Consumer Disputes Redressal Commission under the Consumer Protection Act, 2019 and the civil court. The Supreme Court in National Insurance Co. Ltd. v Hindustan Safety Glass Works Ltd., (2017) 5 SCC 776 and in Galada Continental Pvt. Ltd. v Union of India, (2016) 12 SCC 152 has refused to allow insurers to retreat behind technical clauses where conduct shows waiver or acquiescence. This guide sets out the framework and the denial routes as they now operate.

Cashless treatment is, in the working sense, the arrangement under which a hospitalised policyholder does not pay the hospital bill at discharge — the insurer or its third-party administrator settles the bill directly with the network hospital against the pre-authorised limit and the policy entitlement. The arrangement rests on three pillars: a tie-up between the insurer and the hospital (the empanelment or network agreement), a pre-authorisation request raised by the hospital to the insurer or the TPA before treatment begins, and a discharge-stage final authorisation that settles the actual bill against the policy. Each pillar is regulated. The IRDAI (Health Insurance) Regulations, 2016 and the IRDAI Master Circular on Standardisation in Health Insurance Business, 2020 prescribe the contractual architecture; the IRDAI (Protection of Policyholders' Interests) Regulations, 2017 prescribe the turn-around-times and the policyholder-facing service standards; the IRDAI Health Insurance (Standardisation) Guidelines, 2022 modified the standardisation regime in 2022; and the IRDAI Circular on "Cashless Everywhere" dated 31 January 2024 widened the cashless facility beyond strict empanelment in certain situations. A denial that does not respect this architecture is challengeable.

The contractual architecture — the policy, the network, the TPA

A health-insurance policy in India is a contract of indemnity governed by the Insurance Act, 1938 and the regulations made under the Insurance Regulatory and Development Authority Act, 1999. The policy specifies the sum insured, the covered conditions, the exclusions and the sub-limits, in the form prescribed by the IRDAI (Health Insurance) Regulations, 2016 and the standardised definitions issued under the IRDAI Master Circular on Standardisation in Health Insurance Business dated 22 July 2020 (IRDAI/HLT/REG/CIR/177/07/2020) and the IRDAI Health Insurance (Standardisation) Guidelines, 2022. The Standardisation Master Circular replaced an earlier 2013 standardisation regime and consolidates the standard definitions of "hospital", "in-patient care", "day-care procedure", "pre-existing disease", "AYUSH treatment" and similar terms that every health-insurance policy in India must adopt verbatim.

Cashless treatment sits on a tie-up between the insurer and the hospital. Under Regulation 31 of the IRDAI (Health Insurance) Regulations, 2016 — read with the standardisation circular — an insurer is to maintain a list of network providers (hospitals it has empanelled) and is to publish that list on its website and make it available to policyholders. The empanelment carries a contractual pricing arrangement: the package rates for the standard procedures, the rate for the room category covered by the policy, and the cashless processing protocol. The hospital agrees to bill the insurer at those rates; the insurer agrees to settle the bill, subject to the policy terms, within the regulated turn-around-time.

The third-party administrator (TPA) sits in between. The IRDAI (Third Party Administrators — Health Services) Regulations, 2016 govern TPA licensing and the contractual relationship between the insurer and the TPA. The TPA is the insurer's processing arm for health claims: it receives the pre-authorisation request from the hospital, checks the policy and the medical documentation, and either grants the pre-authorisation up to a stated amount or asks for further information. The TPA's decision is, in legal terms, the insurer's decision — the TPA is the insurer's agent under the regulations, and a denial by the TPA is reviewable on the same footing as a denial by the insurer directly. The 2016 TPA regulations also impose service-quality obligations on TPAs, including a complaint-redressal mechanism that runs in parallel with the insurer's own grievance redressal cell under Regulation 17 of the 2017 Protection of Policyholders' Interests Regulations.

The pre-authorisation turn-around-time

The most operationally consequential rule for a policyholder lying on a hospital bed is the turn-around-time for pre-authorisation. Regulation 9 of the IRDAI (Protection of Policyholders' Interests) Regulations, 2017 — read with Clause F of the IRDAI Master Circular on Standardisation in Health Insurance Business, 2020 — fixes the time within which the insurer or its TPA must communicate a decision on a cashless request. For planned hospitalisation, the pre-authorisation must be communicated within the time prescribed in the policy and, in any event, before the admission. For emergency hospitalisation, the standardisation circular requires the insurer to respond to a pre-authorisation request within one hour of receipt of the complete request from the hospital; at discharge, the final authorisation must issue within three hours of receipt of the complete discharge request.

What "complete request" means is the operational fulcrum. The hospital is required to submit the IRDAI standard pre-authorisation form (Annexure to the Master Circular, 2020) along with the policy number, the patient identification, the treating doctor's note, the proposed line of treatment, the estimated cost and any prior medical records relevant to the condition. If the TPA seeks further information, the clock for the one-hour TAT pauses until the further information is supplied. The IRDAI Standardisation Guidelines, 2022 require this query-and-response cycle to be confined to one query, save in exceptional cases — the insurer cannot, as some had been doing, raise serial queries to defer the decision indefinitely. A breach of the turn-around-time is a regulatory violation that the IRDAI may, under Section 14 of the IRDA Act, 1999, address through its supervisory powers, and is also a service deficiency under Section 2(11) of the Consumer Protection Act, 2019 actionable before the consumer forum.

The IRDAI Circular on "Cashless Everywhere" dated 31 January 2024 (Ref. IRDAI/HLT/MISC/CIR/22/01/2024) widened the cashless facility further. Under the 2024 framework, a policyholder admitted to a hospital that is not formally in the insurer's network may still apply for cashless treatment — the insurer is required to facilitate cashless settlement at non-network hospitals through an extended protocol, with a 48-hour pre-authorisation window for elective admissions and a one-hour window for emergencies. The circular is binding on all general and health insurers carrying on health-insurance business in India; the operational rollout has been uneven, but the legal entitlement is now in place.

Permissible grounds of denial

An insurer or TPA may refuse cashless authorisation only on grounds that are permitted by the policy terms and the regulatory framework. The recognised heads of denial are five. The first is non-coverage — the condition or the line of treatment is excluded under the policy. Common exclusions are the waiting period for specified illnesses, the pre-existing-disease exclusion (subject to the 36-month or 48-month waiting period prescribed under the Standardisation Master Circular for new-generation policies and the staggered transition for older policies), the cosmetic-procedure exclusion, the experimental-treatment exclusion and the war-and-nuclear-risks exclusion. The second is non-disclosure or misrepresentation — the insurer may decline cashless on the ground that material facts were suppressed at the proposal stage, subject to Section 45 of the Insurance Act, 1938 (no policy may be called in question after three years on grounds of misstatement, fraud excepted).

The third is premium default — under Section 64-VB of the Insurance Act, 1938, the risk is on the insurer only against premium received in advance. A policy in lapse for non-payment of premium will not support a cashless authorisation. The fourth is exhaustion of the sum insured or the sub-limit — a policyholder who has exhausted the sum insured for the policy year, or the sub-limit for the room category or the specified procedure, will not receive cashless authorisation beyond that limit. The fifth is non-network hospital — historically, cashless was confined to network hospitals; post the 2024 Cashless Everywhere circular, the residual gap has narrowed. Outside these five heads, a denial is suspect. The IRDAI Standardisation Master Circular, 2020 and the 2017 Protection of Policyholders' Interests Regulations require the denial communication to specify, in writing, the precise clause of the policy under which the cashless authorisation is being declined.

The doctrine of uberrima fides — utmost good faith — that runs through the law of insurance in India under LIC of India v Asha Goel, (2001) 2 SCC 160 and the line of cases since Mithoolal Nayak v LIC of India, AIR 1962 SC 814 binds both parties. An insurer who relies on the non-disclosure ground must show that the suppression was on a material matter, was fraudulent, and was known to the policyholder to be material at the time the proposal was made — the three conditions read into Section 45 of the 1938 Act by Mithoolal Nayak and reaffirmed by Asha Goel. A casual suppression that is not material, or a disclosure made innocently, will not support repudiation either at the cashless stage or at the final claim.

Waiver and acquiescence — the Galada Continental line

The Supreme Court has, in a line of decisions, refused to allow insurers to take refuge in technical clauses where the conduct of the parties shows waiver or acquiescence. The doctrinal anchor for the policyholder is Galada Continental Pvt. Ltd. v Union of India, (2016) 12 SCC 152. The insured had filed a fire-insurance claim; the insurer had repudiated on the ground of delayed intimation, a contractual breach of the policy condition. The Supreme Court held that where the insurer had, by its conduct after receiving the intimation, treated the claim as live — appointed a surveyor, conducted investigations, sought further information — it had waived the technical breach. The clause survived as a contractual term, but the insurer's conduct precluded reliance on it.

The Court restated the principle in National Insurance Co. Ltd. v Hindustan Safety Glass Works Ltd., (2017) 5 SCC 776. The two-judge Bench (Madan B Lokur and Deepak Gupta JJ) held that an insurer cannot rely on a clause requiring claims to be filed within twelve months of the loss, where the insurer's own conduct — by continuing to correspond with the insured, calling for more documents, deferring its decision — had induced the insured to believe that the claim was being processed on the merits. The opening passage of the judgment is now routinely cited in pre-authorisation disputes: "An insurance company cannot rely on a clause in the insurance policy to take advantage of its own wrong and avoid liability". The principle has been applied in the cashless context by State Consumer Commissions — where an insurer had granted an initial pre-authorisation, then revoked it at the discharge stage on a clause it had not raised earlier, the revocation was held to be precluded by acquiescence.

The Court's older formulation in Oriental Insurance Co. Ltd. v Sony Cheriyan, (1999) 6 SCC 451 — that an insurance contract is to be construed strictly on its terms and the court will not read into the policy a coverage that the parties did not intend — remains good law for the substantive coverage question. The Galada / Hindustan Safety Glass line operates on the procedural side: even where the substantive coverage is contested, the insurer cannot operate the contractual machinery in a manner that defeats the policyholder's reasonable expectation built on the insurer's own conduct. The two doctrines sit together. The substantive question — is the condition or treatment covered — is decided on the policy text; the procedural question — has the insurer behaved consistently with the contract — is decided on conduct.

The grievance route — IRDAI IGMS and the insurer's grievance cell

The first denial route — and the one that resolves the largest share of pre-authorisation disputes — is the regulator's grievance-management system. Regulation 17 of the IRDAI (Protection of Policyholders' Interests) Regulations, 2017 requires every insurer to maintain a grievance redressal cell, headed by a Grievance Redressal Officer (GRO) at the head office and in each branch, with prescribed turn-around-times for acknowledgement (three days from receipt) and resolution (fifteen days from receipt). A complaint not resolved within fifteen days, or resolved unsatisfactorily, is escalated to the IRDAI Integrated Grievance Management System (IGMS), the regulator's online portal. The IGMS issues a complaint number, routes the complaint to the insurer and tracks the resolution; an unresolved complaint after thirty days at the insurer's end may be escalated to the IRDAI Consumer Affairs Department for supervisory intervention.

The IGMS is not a quasi-judicial forum — it does not adjudicate the claim. Its function is to compel the insurer to apply its mind to the complaint within the regulatory timeline and to record a reasoned decision. For a policyholder whose denial is patently outside the five permitted heads, or whose pre-authorisation has been delayed past the one-hour or three-hour TAT, the IGMS route often produces a reversal within a fortnight without further litigation. The denial communication remains, however, the gateway document for the next stage — if the insurer issues a written denial citing a specific policy clause, that document is the basis on which the policyholder may approach the Insurance Ombudsman or the consumer forum.

The Insurance Ombudsman route — 1998 to 2017 and the 2021 amendment

The Insurance Ombudsman is the principal extra-judicial forum for individual insurance disputes in India. The institution was created under the Insurance Ombudsman Rules, 1998 made by the Central Government under Section 24 of the IRDA Act, 1999. The 1998 Rules were superseded by the IRDAI Integrated Insurance Ombudsman Scheme, 2017, notified by the Department of Financial Services and administered through the Council for Insurance Ombudsmen. The 2017 Scheme was substantially amended by the Insurance Ombudsman (Amendment) Rules, 2021 — the amendment widened the Ombudsman's pecuniary jurisdiction to claims up to Rs 50 lakh (from Rs 30 lakh under the 1998 Rules and Rs 30 lakh under the 2017 Scheme), permitted electronic filing of complaints, introduced video-hearings and gave the Ombudsman power to pass an award binding on the insurer if accepted by the complainant within thirty days.

An Ombudsman complaint is filed under Rule 14 of the 2017 Scheme as amended. The pre-conditions are three: a written representation to the insurer rejected or unanswered for more than one month, the complaint within one year of the rejection or the cause of action, and the complaint not pending before a civil court or consumer forum. The Ombudsman holds a summary hearing, may mediate a settlement, and where mediation fails, passes a recommendation or an award. An award up to Rs 50 lakh, if accepted by the complainant within thirty days, is binding on the insurer; the insurer must comply within thirty days of receipt of acceptance, failing which the complainant may file the award for enforcement. The Ombudsman route is free for the complainant, runs on a six-month-or-less timeline, and is the most cost-efficient forum for cashless-denial disputes in the Rs 1 lakh to Rs 50 lakh band.

The consumer-forum route — IMA v Shantha and the post-2019 framework

The Consumer Protection Act, 2019 carries forward the consumer-forum jurisdiction over insurance disputes that was settled under the 1986 Act by Indian Medical Association v V P Shantha, (1995) 6 SCC 651 (medical services as "service") and the line of insurance-specific cases beginning with Lucknow Development Authority v M K Gupta, (1994) 1 SCC 243 (statutory authorities as service providers). An insurance policy is a contract for "service" under Section 2(42) of the 2019 Act; a denial of cashless authorisation in breach of the policy or the regulatory framework is a "deficiency in service" under Section 2(11); the consumer is a "consumer" under Section 2(7); and the policyholder may file a complaint before the District Consumer Disputes Redressal Commission under Section 34 of the 2019 Act for claims up to Rs 50 lakh, the State Commission under Section 47 for claims between Rs 50 lakh and Rs 2 crore, and the National Commission under Section 58 for claims above Rs 2 crore.

The proof requirement before the consumer forum is preponderance of probabilities. The complainant produces the policy, the pre-authorisation request, the denial communication and the medical records; the insurer produces the policy terms relied upon and the underwriting record. The forum applies the contractual terms in the light of the IRDAI regulations, the standardisation circular and the Galada / Hindustan Safety Glass line on waiver. Compensation is awarded for the unreimbursed hospital bill, the interest on that amount from the date of denial, the cost of the parallel non-cashless out-of-pocket payment that the policyholder had to arrange, and, where the forum is satisfied that the denial was arbitrary, additional compensation for mental harassment under Section 39 of the 2019 Act.

The Supreme Court in United India Insurance Co. Ltd. v M/s Manubhai Dharmasinhbhai Gajera, (2008) 10 SCC 404 — though pre-dating the 2019 Act — laid down the standard the consumer forum is to apply in insurance-claim disputes: the insurer is bound to honour the policy on its terms, the burden to prove a contractual exclusion or breach lies on the insurer, and a denial unsupported by the policy text or unsupported by the surveyor's report cannot survive scrutiny. The Court in Export Credit Guarantee Corpn. v Garg Sons International, (2014) 1 SCC 686 added the principle that ambiguity in a policy term is to be construed against the insurer (contra proferentem) — a rule of construction that runs in favour of the policyholder in cashless-denial disputes where the disputed clause is the exclusion clause drafted by the insurer.

The civil-court residual route and the choice of forum

The civil suit under Section 9 of the Code of Civil Procedure, 1908 remains the residual route for an insurance dispute. It is the appropriate forum where the dispute involves complex factual issues unsuited to the summary procedure of the consumer forum, where the claim exceeds the National Commission's pecuniary jurisdiction at Rs 2 crore, or where the policyholder seeks declaratory or injunctive relief alongside damages. The limitation is three years under Article 44 of the Schedule to the Limitation Act, 1963 (suit by an assured against an insurer on a policy of insurance, running from the date the loss occurs, or where the claim is for the policy money or interest, from the date the cause of action accrues).

The choice between the Ombudsman, the consumer forum and the civil court turns on three factors. The first is the amount in dispute — for a cashless denial under Rs 50 lakh, the Ombudsman is the fastest and cheapest forum, with the consumer forum as the second-line option if the Ombudsman's award is not accepted; for larger claims, the consumer forum is the default, with the civil court reserved for cases that exceed Rs 2 crore or that involve complex evidentiary disputes. The second is the relief sought — the Ombudsman and the consumer forum can award compensation but cannot grant declaratory or injunctive relief; the civil court can grant all three. The third is the parallel-jurisdiction bar — under Rule 14 of the 2017 Ombudsman Scheme, a complaint pending before a civil court or consumer forum is not entertained; the policyholder must elect a forum and stay with it.

Constitutional remedies and writ jurisdiction

For policyholders insured by the public-sector general insurance companies (the four PSU general insurers and the LIC) and the public-sector Employees' State Insurance Corporation, the writ jurisdiction under Articles 226 and 32 of the Constitution is, in some circumstances, available. The Supreme Court has held that a writ may issue against a public-sector insurer where the denial is shown to be arbitrary, in breach of the regulatory framework, or in violation of the right to health read into Article 21 — though the Court in LIC of India v Asha Goel, (2001) 2 SCC 160 confined the writ route to cases involving important questions of law or constitutional issues, declining to allow the writ jurisdiction to substitute for ordinary contractual remedies. The writ is, in practice, a residual route reserved for systemic denials or denials by public bodies that are administratively reviewable. For a routine cashless denial by a private-sector insurer, the writ jurisdiction is not available.

What the framework produces — and what it does not

The cashless framework after the 2016 IRDAI Health Insurance Regulations, the 2020 Standardisation Master Circular, the 2022 Standardisation Guidelines and the 2024 Cashless Everywhere circular produces, in working effect, a regulatory baseline: a one-hour pre-authorisation TAT for emergencies, a three-hour discharge TAT, a network architecture that is now widened to include non-network cashless settlement, a standardised pre-authorisation form, a written denial that must specify the policy clause, and a four-tier denial-review architecture — the insurer's GRO, the IRDAI IGMS, the Insurance Ombudsman and the consumer forum, with the civil court and the writ jurisdiction as residual options. The Supreme Court's contribution in Galada Continental and Hindustan Safety Glass sits on top — the insurer cannot rely on a clause it has waived, and ambiguity is read against the drafter.

What the framework does not produce is uniformity. The TAT breach is widely under-enforced; pre-authorisation disputes at the discharge stage — where the hospital and the TPA negotiate the bill in real time and the patient is the residual loser — continue to be the largest category of complaints to the Insurance Ombudsmen. The Cashless Everywhere circular is operationally patchy: a policyholder admitted to a hospital genuinely outside the insurer's network may find the 48-hour pre-authorisation window honoured in some states and not others. The IRDAI has, in 2024 and 2025, issued follow-up advisories tightening compliance, but the rollout remains uneven.

The practical takeaway for a researcher reading the framework is that the denial of cashless authorisation is, in the great majority of cases, reviewable. Where the denial is on a permitted ground — the condition is genuinely excluded, the policy is in lapse, the sum insured is exhausted — the dispute is on the merits and is properly fought before the Ombudsman or the consumer forum on the policy text. Where the denial is on a technical ground — late intimation, missing document, clause not earlier raised — the Galada / Hindustan Safety Glass line gives the policyholder a strong waiver argument. Where the denial breaches the regulatory TAT, the dispute is, in addition, a regulatory violation actionable through the IGMS and reportable to the IRDAI's supervisory wing. The cashless authorisation is, in law, a contractual entitlement; the architecture for vindicating that entitlement is now reasonably well-developed.